SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-09-062713
Filing Date
2009-11-05
Accepted
2009-11-05 08:43:06
Documents
11
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a09-31170_110q.htm 10-Q 1417762
2 EX-4.3 a09-31170_1ex4d3.htm EX-4.3 35242
3 EX-31.1 a09-31170_1ex31d1.htm EX-31.1 11722
4 EX-31.2 a09-31170_1ex31d2.htm EX-31.2 11455
5 EX-32.1 a09-31170_1ex32d1.htm EX-32.1 6178
6 EX-32.2 a09-31170_1ex32d2.htm EX-32.2 6258
7 GRAPHIC g311701kei001.jpg GRAPHIC 8220
8 GRAPHIC g311701kei002.gif GRAPHIC 3385
9 GRAPHIC g311701kei003.jpg GRAPHIC 8379
10 GRAPHIC g311701kei004.jpg GRAPHIC 2918
11 GRAPHIC g311701kei005.jpg GRAPHIC 2694
  Complete submission text file 0001104659-09-062713.txt   1526125
Mailing Address 100 HAYDEN AVENUE LEXINGTON MA 02140
Business Address 100 HAYDEN AVENUE LEXINGTON MA 02140 6174972070
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10865 | Film No.: 091159591
SIC: 2835 In Vitro & In Vivo Diagnostic Substances